California Institute for regenerative medicine
The State stem cell agency
University of California, Los Angeles
Awards as PI
Tools and Technologies II
Use of hiPSCs to develop lead compounds for the treatment of genetic diseases
Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions.
Nat Commun 2013
SMRT compounds abrogate cellular phenotypes of ataxia telangiectasia in neural derivatives of patient-specific hiPSCs.